These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4570868)

  • 1. [Follow-ups after kidney transplantations].
    Halbfass HJ; Staib I; Heinze V; Jontofsohn R; Junkers K
    Dtsch Med Wochenschr; 1973 Mar; 98(10):479-81. PubMed ID: 4570868
    [No Abstract]   [Full Text] [Related]  

  • 2. Prednisone used as treatment for rejection correlates with poor outcome.
    Toussaint RM; Callender CO; Dunston GM; Flores J; Walters CS; John D; Yeager C; Bond O; Thompson C; Gear JC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical use of rabbit antihuman lymphocyte globulin in cadaver-kidney transplantation.
    Mannick JA; Davis RC; Cooperband SR; Glasgow AH; Williams LF; Harrington JT; Cavallo T; Schmitt GW; Idelson BA; Olsson CA; Nabseth DC
    N Engl J Med; 1971 May; 284(20):1109-15. PubMed ID: 4928659
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis affecting hemodialysis and transplant patients. Its considerations and consequences.
    Briggs WA; Lazarus JM; Birtch AG; Hampers CL; Hager EB; Merrill JP
    Arch Intern Med; 1973 Jul; 132(1):21-8. PubMed ID: 4577389
    [No Abstract]   [Full Text] [Related]  

  • 5. Quadruple therapy for cadaver renal transplantation.
    Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
    [No Abstract]   [Full Text] [Related]  

  • 6. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
    Light JA; Aquino A; Ali A; Rodriguez R; Ali S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
    [No Abstract]   [Full Text] [Related]  

  • 7. Preliminary studies on antithymocyte globulin.
    Orlowski T; Skopińska E; Kossowska-Paul B; Wasik M; Wojtulewicz-Kurkus J; Klopotowska E; Tupalska B; Filipowicz Z
    Pol Med J; 1971; 10(2):400-7. PubMed ID: 4997629
    [No Abstract]   [Full Text] [Related]  

  • 8. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
    Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract]   [Full Text] [Related]  

  • 10. Chagas disease and transplantation.
    Vazquez MC; Sabbatiello R; Schiavelli R; Maiolo E; Jacob N; Pattin M; Rearte A
    Transplant Proc; 1996 Dec; 28(6):3301-3. PubMed ID: 8962281
    [No Abstract]   [Full Text] [Related]  

  • 11. Causes of allograft failure in recipients treated with and without antilymphocyte globulin.
    Sheil AG; May J; Rogers JH; Storey BG; Katran DC; Duggin GG; Johnson JR; Stewart JH
    Transplant Proc; 1973 Mar; 5(1):561-5. PubMed ID: 4121179
    [No Abstract]   [Full Text] [Related]  

  • 12. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E; Robinson C; Bear R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical renal transplantation.
    Sommer BG; Ferguson RM; Najarian JS
    Urol Clin North Am; 1983 Feb; 10(1):149-59. PubMed ID: 6340311
    [No Abstract]   [Full Text] [Related]  

  • 14. Review of human renal transplantation at the Toronto General Hospital.
    Farrow GA; Wilson DR; Fenton SS; Hayman WP
    Can J Surg; 1973 Mar; 16(2):134-8. PubMed ID: 4570266
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors in infectious complications following cadaver renal transplantation.
    Thomas F; Lee HM; Wolf JS; Thomas J
    Proc Clin Dial Transplant Forum; 1973; 3():196-9. PubMed ID: 4619681
    [No Abstract]   [Full Text] [Related]  

  • 16. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
    Canafax DM; Savik SK; Draxler CA; Le CT; Ascher NL; Payne WD; Sutherland DE; Migliori RJ; Simmons RL; Najarian JS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of OKT3 in kidney, pancreas, and liver transplantation.
    D'Alessandro AM; Pirsch JD; Melzer JS; Sollinger HW; Kalayoglu M; Reed A; Knechtle SJ; Belzer FO
    Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
    [No Abstract]   [Full Text] [Related]  

  • 18. Results of the kidney transplantation in the Warsaw Center.
    Nielubowicz J; Orlowski T; Wesolowski S; Falda Z; Gradowska L; Rowińska D; Rowiński W; Skośkiewicz M; Szostek M; Filipowicz Z; Glyda J; Goliszek Z; Jedrzejewski R; Kardasiewicz W; Klepacka J; Klopotowska E; Kossowska B; Koziak H; Krzywicka E; Lao M; Ladygin J; Marzinek B; Miller J; Michalowicz B; Machowski Z; Olszewski K
    Pol Med J; 1971; 10(2):340-3. PubMed ID: 4104328
    [No Abstract]   [Full Text] [Related]  

  • 19. Late acute rejection in renal transplant recipients: response to steroid treatment.
    Prieto C; Pulido F; Rodríguez-Paternina E; Algranati C; Bello I; Farias J; G-Millet V
    Transplant Proc; 1992 Feb; 24(1):35-6. PubMed ID: 1539312
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
    Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.